logo
Sign InSign Up

PFIZER INC (PFE)

Sector: Healthcare

Financial Fundamentals

findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for PFE, sign up here.

Income Statement

Revenue

$58.5bn

Gross Profit

$33.5bn

Earning before Tax

$1.0bn

Net Income

$2.1bn

Net Income Common Shareholders

$2.1bn

EPS

0.38

Balance Sheet

Cash

$2.9bn

Debt

$71.9bn

Assets

$226.5bn

Liabilities

$137.2bn

Equity

$89.0bn

Enterprise Value

$223.0bn

Cash Flow Statement

Net Cash from Operations

$8.7bn

Net Cash from Investing

$-32.3bn

Net Cash from Financing

$26.1bn

Net Cash Flow

$2.4bn

Free Cash Flow

$4.8bn

Free Cash Flow per Share

$0.85

Metrics

Price to Equity

76.72

Price to Equity (Damodaran)

75.76

Price to Book

1.83

Net Margin

0.04

Return on Equity

0.02

Return on Sales

0.02

Get immediate access to 5-years of reference grade data for PFE for free.

Sign up

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women''s health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; Abrocitinib, under CIBINQO; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Company Info

Industry

Drug Manufacturers - General

Employees

Address

66 Hudson Boulevard East
New York, NY 10001-2192
United States

Phone

212 733 2323

Last Updated

2024-02-19

Available Data

Standardized Financial Statements

EOD Price History

Corporate Actions

Institutional Holdings

Insider Transactions

Sign up for free and get immediate access
logo

Radically accessible financial data

Contact Info

findl.com info@findl.com

Explore findl data

DocumentationSupport

Copyright © findl 2024. All rights reserved.

Terms & Use

Privacy Policy